A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors
Clinical trial NCT03042910 · COMPLETED
Trial details
- NCT number
- NCT03042910
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-13
- Primary completion
- 2017-05-30
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.